These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tyrosinemia with plantar and palmar keratosis and keratitis. Goldsmith LA; Kang E; Bienfang DC; Jimbow K; Gerald P; Baden HP J Pediatr; 1973 Nov; 83(5):798-805. PubMed ID: 4270265 [No Abstract] [Full Text] [Related]
4. Tyrosinemia without liver or renal damage with plantar and palmar keratosis and keratitis (hypertyrosinemia type II). Pelet B; Antener I; Faggioni R; Spahr A; Gautier E Helv Paediatr Acta; 1979 May; 34(2):177-83. PubMed ID: 156708 [TBL] [Abstract][Full Text] [Related]
5. Painful keratoderma and photophobia: hallmarks of tyrosinemia type II. Rabinowitz LG; Williams LR; Anderson CE; Mazur A; Kaplan P J Pediatr; 1995 Feb; 126(2):266-9. PubMed ID: 7844676 [TBL] [Abstract][Full Text] [Related]
6. Richner-Hanhart syndrome and tyrosinemia type II. Hunziker N Dermatologica; 1980; 160(3):180-9. PubMed ID: 6446465 [TBL] [Abstract][Full Text] [Related]
11. Tyrosinemia type II in two cases previously reported as Richner-Hanhart syndrome. Balato N; Cusano F; Lembo G; Santoianni P Dermatologica; 1986; 173(2):66-74. PubMed ID: 2947825 [TBL] [Abstract][Full Text] [Related]
15. Palmoplantar keratoderma with normal intelligence in tyrosinaemia II. Danks DM; Callan NJ Australas J Dermatol; 1988; 29(2):107-9. PubMed ID: 2978637 [No Abstract] [Full Text] [Related]
16. Familial tyrosinaemia with eye and skin lesions. Presentation of two cases. Bardelli AM; Borgogni P; Farnetani MA; Fois A; Frezzotti R; Mattei R; Molinelli M; Sargentini I Ophthalmologica; 1977; 175(1):5-9. PubMed ID: 20595 [TBL] [Abstract][Full Text] [Related]
17. Hepatic tyrosine aminotransferase in tyrosinaemia type II. Kida K; Takahashi M; Fujisawa Y; Matsuda H; Machino H; Miki Y J Inherit Metab Dis; 1982; 5(4):229-30. PubMed ID: 6133036 [No Abstract] [Full Text] [Related]
18. [Oculo-cutaneous tyrosinosis (Richner-Hanhart syndrome). Histo-pathological study of a case]. Larregue M; de Giacomoni P; Odievre M; Babin P; Lorette G Ann Anat Pathol (Paris); 1980; 25(3):185-200. PubMed ID: 6112939 [TBL] [Abstract][Full Text] [Related]
19. Dietary treatment of tyrosinemia type I: importance of methionine restriction. Michals K; Matolon R; Wong PW J Am Diet Assoc; 1978 Nov; 73(5):507-14. PubMed ID: 701680 [TBL] [Abstract][Full Text] [Related]
20. [Oculocutaneous type II tyrosinosis]. Podglajen-Wecxsteen O; Delaporte E; Piette F; le Flohic X; Bergoend H Ann Dermatol Venereol; 1993; 120(2):139-42. PubMed ID: 8363306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]